Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program-Reference-Cited by-同舟云学术

Medicare Part D Coverage of Drugs Selected for the Drug Price Negotiation Program

Published:2024-02-09 Issue:2 Volume:5 Page:e235237
ISSN:2689-0186
Container-title:JAMA Health Forum
language:en
Short-container-title:JAMA Health Forum

Author:

Patterson Julie A.¹,Wagner Tyler D.¹,O’Brien John M.¹,Campbell Jonathan D.¹

Affiliation:

1. National Pharmaceutical Council, Washington, DC

Abstract

This cross-sectional study describes and historically benchmarks Medicare Part D coverage in 2019 and 2023 for the first 10 drugs selected for negotiation.

Publisher

American Medical Association (AMA)

Link

https://jamanetwork.com/journals/jama-health-forum/articlepdf/2814988/patterson_2024_ld_230042_1707322264.70912.pdf

Reference6 articles.

1. The Inflation Reduction Act: how will Medicare negotiating drug prices impact patients with heart disease?;Johnson;Curr Cardiol Rep,2023

2. Coverage, formulary restrictions, and out-of-pocket costs for sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in the Medicare Part D program.;Luo;JAMA Netw Open,2020

3. Out-of-pocket costs of specialty medications for psoriasis and psoriatic arthritis treatment in the Medicare population.;Pourali;JAMA Dermatol,2021

4. Commercial coverage of specialty drugs, 2017–2021.;Rucker;Health Aff Sch,2023

5. Seshamani? M. Medicare Drug Price Negotiation Program: revised guidance, implementation of sections 1191-1198 of the Social Security Act for initial price applicability year 2026. Centers for Medicare & Medicaid Services. June 30, 2023. Accessed August 26, 2023. https://www.cms.gov/files/document/revised-medicare-drug-price-negotiation-program-guidance-june-2023.pdf

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is It Working? Evaluating The First Round Of Medicare Drug Price Negotiations;Health Affairs;2024-09-01